Computer Aided Detection Market
Computer Aided Detection Market Forecasts to 2030 - Global Analysis By Product Type (Abdominal CAD, Prostrate CAD, Breast CAD, Cardiovascular CAD and Other Product Types), Indication (Ultrasound Resonance Imaging, X-ray Imaging, Magnetic Resonance Imaging, Computed Tomography, Nuclear Resonance Imaging, Mammography and Other Indications), Application, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $818 MN |
|
Projected Year Value (2030) |
US $1,392 MN |
|
CAGR (2023 - 2030) |
7.9% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
North America |
According to Stratistics MRC, the Global Computer Aided Detection Market is accounted for $818 million in 2023 and is expected to reach $1,392 million by 2030 growing at a CAGR of 7.9% during the forecast period. Computer-aided detection (CAD) is a collection of algorithms that use pattern recognition to help physicians interpret medical images. The computer-aided detection software aids in the diagnosis of various diseases, including coronary artery disease, cancer, cardiovascular diseases, and neurological diseases, through imaging modalities such as x-ray imaging, magnetic resonance imaging, ultrasound imaging, and computed tomography.
According to the World Health Organization (WHO) estimates, in 2022, cancer is the leading cause of death worldwide, resulting in approximately 10 million deaths in 2020, or nearly one in six deaths.
Market Dynamics:
Driver:
Rising demand for early disease detection
Early detection of diseases is crucial, as it enhances the chances of successful treatment and improves patient outcomes. CAD systems integrated with imaging modalities analyze the images and highlight potential areas of concern, aiding radiologists in the early detection of diseases. Moreover, the rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has heightened the need for early diagnosis. Therefore, growing demand for early disease detection is a significant driver accelerating market demand.
Restraint:
High implementation costs
High implementation costs pose a significant restraint to the adoption of computer-aided detection (CAD) systems on the market. Implementing CAD systems requires substantial investment, which includes the cost of acquiring the software, hardware infrastructure, and training of healthcare professionals. CAD software itself can be expensive, especially if it is designed for specific medical specialties or imaging modalities. Additionally, the hardware requirements to support CAD systems, such as high-performance computers and storage solutions, can add to the overall implementation costs.
Opportunity:
Evolution of medical imaging technologies
The continuous evolution of medical imaging technologies, such as computed tomography (CT), magnetic resonance imaging (MRI), and mammography, has paved the way for more sophisticated and detailed diagnostic capabilities. These advancements not only enhance the quality of medical imaging but also create opportunities for CAD systems to excel in their ability to detect subtle abnormalities and assist healthcare professionals in making accurate diagnoses. These innovations in medical imaging technologies accelerate market expansion.
Threat:
Data privacy
The implementation of CAD involves the processing and storage of sensitive patient data, including medical images and associated health records. As CAD systems analyze and interpret this information, there is a heightened concern for potential breaches and unauthorized access. Maintaining the privacy and security of patient data is crucial to complying with healthcare regulations and building trust among patients and healthcare providers. Therefore, data privacy is a significant concern, hindering market demand.
Covid-19 Impact
The increased focus on healthcare and diagnostics during the pandemic has underscored the importance of advanced technologies like CAD in detecting and monitoring diseases. The demand for more accurate and efficient diagnostic tools has risen, driving interest in CAD solutions that can aid in the interpretation of medical images, especially in the context of respiratory illnesses such as COVID-19. However, the pandemic has also presented challenges for the CAD market. Financial constraints on healthcare facilities, coupled with disruptions in the supply chain, have affected the adoption of CAD systems.
The nuclear resonance imaging segment is expected to be the largest during the forecast period
The nuclear resonance imaging segment is estimated to hold the largest share. In computer-aided detection, nuclear resonance imaging plays a significant role in enhancing the accuracy and efficiency of image analysis. CAD systems utilize the detailed images generated by nuclear resonance imaging to identify potential abnormalities or suspicious patterns that may indicate the presence of a disease or condition. Moreover, the integration of NRI with CAD technology has led to improved detection rates, reduced false positives, and enhanced overall diagnostic accuracy.
The oncology segment is expected to have the highest CAGR during the forecast period
The oncology segment is anticipated to have lucrative growth during the forecast period. CAD technologies play a transformative role in oncology by aiding healthcare professionals in the early detection and characterization of cancerous lesions through the analysis of medical imaging data. In modalities like mammography, CT scans, and MRI, CAD systems utilize advanced algorithms to identify subtle abnormalities, potential tumours, and irregularities in tissue structures that may be indicative of cancer.
Region with largest share:
Asia Pacific commanded the largest market share during the extrapolated period. The demand for CAD solutions in this region is escalating due to increasing awareness of the benefits of early disease detection and a rising prevalence of diseases like cancer. Governments across Asia-Pacific are investing significantly in healthcare modernization, fostering an environment conducive to CAD market expansion. Additionally, in countries like China and India, where large populations contribute to a high disease burden, CAD systems are gaining traction for their role in improving diagnostic accuracy and efficiency.
Region with highest CAGR:
North America is expected to witness profitable growth over the projection period, owing to robust healthcare infrastructure, coupled with a high prevalence of chronic diseases, positions CAD as a crucial component in diagnostic workflows. The United States, in particular, dominates the North American CAD market, owing to substantial investments in research and development, a well-established healthcare sector, and a proactive approach to integrating cutting-edge technologies.
Key players in the market
Some of the key players in the Computer Aided Detection Market include Hologic Inc, CANON Medical Systems Corporation, EDDA Technology, Inc, Koninklijke Philips N.V, Siemens, FUJIFILM Holdings Corporation, NANO-X Imaging LTD., General Electric, IBM, Riverain Technologies, iCAD Inc, Median Technologies, Carestream Health, Shimadzu Analytical (India) Pvt. Ltd and Karyopharm.
Key Developments:
In October 2023, Hologic, Inc., a global leader in women’s health, announced an innovative new partnership with the American Association of Gynecologic Laparoscopists (AAGL) and Inovus Medical.
In October 2023, Hologic, Inc., a global leader in women’s health, announced an innovative new partnership with the American Association of Gynecologic Laparoscopists (AAGL) and Inovus Medical. Hologic becomes the chief provider of hystero scopes for AAGL’s Essentials in Minimally Invasive Gynecologic Surgery (EMIGS) hands-on hysteroscopy skills training for OB-GYN residents.
Product Types Covered:
• Abdominal CAD
• Prostrate CAD
• Breast CAD
• Cardiovascular CAD
• Other Product Types
Indications Covered:
• Ultrasound Resonance Imaging
• X-ray Imaging
• Magnetic Resonance Imaging
• Computed Tomography
• Nuclear Resonance Imaging
• Mammography
• Other Indications
Applications Covered:
• Oncology
• Cardiovascular and Neurological Cancer
End Users Covered:
• Diagnostic Centers
• Hospitals
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Computer Aided Detection Market, By Product Type
5.1 Introduction
5.2 Abdominal CAD
5.3 Prostrate CAD
5.4 Breast CAD
5.5 Cardiovascular CAD
5.6 Other Product Types
6 Global Computer Aided Detection Market, By Indication
6.1 Introduction
6.2 Ultrasound Resonance Imaging
6.3 X-ray Imaging
6.4 Magnetic Resonance Imaging
6.5 Computed Tomography
6.6 Nuclear Resonance Imaging
6.7 Mammography
6.8 Other Indications
7 Global Computer Aided Detection Market, By Application
7.1 Introduction
7.2 Oncology
7.2.1 Colorectal Cancer
7.2.2 Breast Cancer
7.2.3 Prostate Cancer
7.2.4 Lung Cancer
7.2.5 Bone Cancer
7.2.6 Liver Cancer
7.3 Cardiovascular and Neurological Cancer
8 Global Computer Aided Detection Market, By End User
8.1 Introduction
8.2 Diagnostic Centers
8.3 Hospitals
8.4 Other End Users
9 Global Computer Aided Detection Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Hologic, Inc
11.2 CANON Medical Systems Corporation
11.3 EDDA Technology, Inc
11.4 Koninklijke Philips N.V
11.5 Siemens
11.6 FUJIFILM Holdings Corporation
11.7 NANO-X Imaging LTD.
11.8 General Electric
11.9 IBM
11.10 Riverain Technologies
11.11 iCAD Inc
11.12 Median Technologies
11.13 Carestream Health
11.14 Shimadzu Analytical (India) Pvt. Ltd
11.15 Karyopharm
List of Tables
1 Global Computer Aided Detection Market Outlook, By Region (2021-2030) ($MN)
2 Global Computer Aided Detection Market Outlook, By Product Type (2021-2030) ($MN)
3 Global Computer Aided Detection Market Outlook, By Abdominal CAD (2021-2030) ($MN)
4 Global Computer Aided Detection Market Outlook, By Prostrate CAD (2021-2030) ($MN)
5 Global Computer Aided Detection Market Outlook, By Breast CAD (2021-2030) ($MN)
6 Global Computer Aided Detection Market Outlook, By Cardiovascular CAD (2021-2030) ($MN)
7 Global Computer Aided Detection Market Outlook, By Other Product Types (2021-2030) ($MN)
8 Global Computer Aided Detection Market Outlook, By Indication (2021-2030) ($MN)
9 Global Computer Aided Detection Market Outlook, By Ultrasound Resonance Imaging (2021-2030) ($MN)
10 Global Computer Aided Detection Market Outlook, By X-ray Imaging (2021-2030) ($MN)
11 Global Computer Aided Detection Market Outlook, By Magnetic Resonance Imaging (2021-2030) ($MN)
12 Global Computer Aided Detection Market Outlook, By Computed Tomography (2021-2030) ($MN)
13 Global Computer Aided Detection Market Outlook, By Nuclear Resonance Imaging (2021-2030) ($MN)
14 Global Computer Aided Detection Market Outlook, By Mammography (2021-2030) ($MN)
15 Global Computer Aided Detection Market Outlook, By Other Indications (2021-2030) ($MN)
16 Global Computer Aided Detection Market Outlook, By Application (2021-2030) ($MN)
17 Global Computer Aided Detection Market Outlook, By Oncology (2021-2030) ($MN)
18 Global Computer Aided Detection Market Outlook, By Colorectal Cancer (2021-2030) ($MN)
19 Global Computer Aided Detection Market Outlook, By Breast Cancer (2021-2030) ($MN)
20 Global Computer Aided Detection Market Outlook, By Prostate Cancer (2021-2030) ($MN)
21 Global Computer Aided Detection Market Outlook, By Lung Cancer (2021-2030) ($MN)
22 Global Computer Aided Detection Market Outlook, By Bone Cancer (2021-2030) ($MN)
23 Global Computer Aided Detection Market Outlook, By Liver Cancer (2021-2030) ($MN)
24 Global Computer Aided Detection Market Outlook, By Cardiovascular and Neurological Cancer (2021-2030) ($MN)
25 Global Computer Aided Detection Market Outlook, By End User (2021-2030) ($MN)
26 Global Computer Aided Detection Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
27 Global Computer Aided Detection Market Outlook, By Hospitals (2021-2030) ($MN)
28 Global Computer Aided Detection Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
